BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -1,558.97 | -2,801.09 | 663.03 | 1,725.83 | 1,453.98 | |
| Net CashFlow From Operating Activities | 148.59 | -2,405.06 | 106.48 | 1,339.18 | 1,223.34 | |
| Net Cash Used In Investing Activities | 2,152.81 | 519.14 | 460.54 | -773.69 | -1,062.69 | |
| Net Cash Used From Financing Activities | -2,674.09 | 1,742.10 | -508.99 | -420.21 | -311.58 | |
| Foreign Exchange Gains / Losses | 1.64 | -1.67 | -4.94 | 3.06 | -1.94 | |
| Adjustments On Amalgamation Merger Demerger Others | 487.93 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 116.88 | -145.49 | 53.09 | 148.34 | -152.87 | |
| Cash And Cash Equivalents Begin of Year | 76.32 | 221.81 | 168.72 | 20.38 | 173.25 | |
| Cash And Cash Equivalents End Of Year | 193.20 | 76.32 | 221.81 | 168.72 | 20.38 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend